Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry

NCT01500759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6876

Last updated 2020-07-09

Study results available
· View outcomes & findings →

Summary

Objective target of the registry is to investigate the prevalence of SDB as well as the clinical characteristics of patients with and without SDB as well as the predominant type of sdb.

For this purpose data from patients suffering from chronic, symptomatic heart failure with impaired left ventricular ejection fraction will be collected prospectively.

Conditions

  • Congestive Heart Failure
  • Left Ventricular Systolic Dysfunction

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Erland Erdmann, Prof · Klinikum der Universität zu Köln

  • Helmut Teschler, Prof · Ruhrlandklinik Essen

  • Holger Woehrle, MD · ResMed

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Australia
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500759 on ClinicalTrials.gov